Cytosorbents Corp
CTSO
51 hedge funds and large institutions have $28.7M invested in Cytosorbents Corp in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 11 closing their positions.
150% more call options, than puts
Call options by funds: $10K | Put options by funds: $4K
4% more capital inflows, than outflows
Capital inflows: $1.29M | Capital outflows: $1.24M
0.3% less ownership
Funds ownership: 34.65% → 34.35% (-0.3%)
11% less funds holding
Funds holding: 57 → 51 (-6)
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Skylands Capital
Milwaukee,
Wisconsin
|
+$434K |
| 2 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$352K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$307K |
| 4 |
Chicago Partners Investment Group
Chicago,
Illinois
|
+$47.6K |
| 5 |
Neuberger Berman Group
New York
|
+$40.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Granahan Investment Management
Waltham,
Massachusetts
|
-$184K |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
-$162K |
| 3 |
Jacob Asset Management of New York
Hermosa Beach,
California
|
-$115K |
| 4 |
BlackRock
New York
|
-$95.5K |
| 5 |
Sargent Investment Group
Bethesda,
Maryland
|
-$93.3K |
CTSO Hedge Fund Activity: Q3 2023 in Review
51 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2023, worth a combined $28.7M — down 48% from $54.7M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CTSO and 6 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 12 added.
The largest buyer was Skylands Capital, adding an estimated $434K. The largest seller was Granahan Investment Management, cutting an estimated $184K.
- 51 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2023, down from 57 in Q2 2023.
- Funds reported $28.7M of Cytosorbents Corp stock for Q3 2023, down 48% quarter-over-quarter.
- 6 funds opened new Cytosorbents Corp positions in Q3 2023 and 11 closed out, a net change of -5 holders.
- The largest Cytosorbents Corp buyer in Q3 2023 was Skylands Capital, an estimated $434K added.
- The largest Cytosorbents Corp seller in Q3 2023 was Granahan Investment Management, an estimated $184K sold.
Based on aggregated 13F filings for Q3 2023.